Category Archives: Cost of healthcare in the U.S.

Diabetes was the condition with the greatest increase in spending

Diabetes sweet on plate

KEY TAKEAWAY: Health care spending in the United States increased by about $933.5 billion between 1996 and 2013, according to an analysis published Tuesday in the medical journal JAMA. Diabetes was the condition with the greatest increase in spending, rising by $64.4 billion between 1996 and 2013. Most of this money went to pharmaceuticals prescribed to treat it. Continue reading

We need prescription drugs to compensate for poor lifestyles

KEY TAKEAWAY: Nearly 40% of adults and 19% of youth are obese , the highest rate the country has ever seen in all adults, according to research released Friday by the National Center for Health Statistics.  This, of course, means that the public is going to be more dependent on prescription drugs to maintain their health at the same time they complain about big pharma. Continue reading

Celgene proves pharma greed is alive and well

KEY TAKEAWAY: A report found that 27 percent of cancer survivors or close relatives of a cancer patient said they’d skipped doctor visits or taken other steps to reduce health costs.  Yet, according to Fierce Pharma  “defying critics in Congress and elsewhere, Celgene hiked the list prices of key cancer meds Revlimid and Pomalyst by 9% this month, taking their cumulative increases for the year to nearly double the range that many Big Pharma peers have pledged to avoid”.  Continue reading

Blaming big pharma for our poor health

According to CNN.com “The United States will not be escaping the obesity epidemic crisis anytime soon: Nearly 40% of adults and 19% of youth are obese, the highest rate the country has ever seen in all adults, according to research released Friday by the National Center for Health Statistics”.  So who is responsible for telling patients to lose weight? Continue reading

“Well, we did something” California’s pharma pricing bill

Ed Silverman at Pharmalot conducted a very revealing interview with California state senator Ed Hernandez, the Democratic legislator who “shepherded the California pharma pricing bill.”

Ed gamely tries to pin down Senator Hernandez on how exactly the bill will make a positive difference. Senator Hernandez seems unable to articulate any particular mechanism of action. His perspective appears to be: “Well, we did SOMETHING.”  They did something because pharma companies have, for the most part, been ignoring the outrage over the high prices of drugs.

Continue reading